Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Edison International price target lowered to $68 from $73 at UBS » 06:22
06/30/22
06/30
06:22
06/30/22
06:22
EIX

Edison International

$62.84 /

+0.49 (+0.79%)

UBS analyst Ross Fowler…

UBS analyst Ross Fowler lowered the firm's price target on Edison International to $68 from $73 and keeps a Neutral rating on the shares as part of a broader research note on North American Power and Utilities. The analyst is shifting to a "less bullish" backdrop and a more "stock-picking environment" focused on lower risk fundamentals and valuation. In some of the prior cycles where the Fed increases rates by 300bp or more, utilities were relative underperformers by double-digit percentages, Fowler tells investors in a research note, stating that he is now changing his view from one where macro tail winds around the Fed raising rates and a recession thesis drove significant rotational fund flows to defense, to one where there are increasing risks of Fed rate hikes beyond 300bp.

ShowHide Related Items >><<
EIX Edison International
$62.84 /

+0.49 (+0.79%)

06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
05/10/22 Mizuho
Edison International downgraded to Neutral from Buy at Mizuho
05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
EIX Edison International
$62.84 /

+0.49 (+0.79%)

EIX Edison International
$62.84 /

+0.49 (+0.79%)

Over a week ago
Conference/Events
Edison International management to meet virtually with Seaport Global » 04:55
06/24/22
06/24
04:55
06/24/22
04:55
EIX

Edison International

$60.71 /

+0.6 (+1.00%)

Virtual Meeting to be…

Virtual Meeting to be held on June 24 hosted by Seaport Global.

ShowHide Related Items >><<
EIX Edison International
$60.71 /

+0.6 (+1.00%)

06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
05/10/22 Mizuho
Edison International downgraded to Neutral from Buy at Mizuho
05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
EIX Edison International
$60.71 /

+0.6 (+1.00%)

EIX Edison International
$60.71 /

+0.6 (+1.00%)

Conference/Events
Edison International management to meet virtually with Seaport Global » 15:46
06/17/22
06/17
15:46
06/17/22
15:46
EIX

Edison International

$58.90 /

-1.37 (-2.27%)

Virtual Meeting to be…

Virtual Meeting to be held on June 24 hosted by Seaport Global.

ShowHide Related Items >><<
EIX Edison International
$58.90 /

-1.37 (-2.27%)

06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
05/10/22 Mizuho
Edison International downgraded to Neutral from Buy at Mizuho
05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
EIX Edison International
$58.90 /

-1.37 (-2.27%)

EIX Edison International
$58.90 /

-1.37 (-2.27%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:59
06/06/22
06/06
09:59
06/06/22
09:59
SPOT

Spotify

$113.53 /

+1.24 (+1.10%)

, CRWD

Crowdstrike

$164.16 /

+2.095 (+1.29%)

, LULU

Lululemon

$302.50 /

+1.6 (+0.53%)

, DASH

DoorDash

$69.18 /

+1.12 (+1.65%)

, ACB

Aurora Cannabis

$1.61 /

+0.01 (+0.63%)

, AXP

American Express

$169.54 /

+2.68 (+1.61%)

, TPTX

Turning Point Therapeutics

$75.05 /

+0.47 (+0.63%)

, BMY

Bristol-Myers

$75.48 /

+0.325 (+0.43%)

, PMVP

PMV Pharmaceuticals

$13.96 /

+0.12 (+0.87%)

, SWTX

SpringsWorks Therapeutics

$21.51 /

-0.11 (-0.51%)

, RVMD

Revolution Medicines

$19.17 /

+0.06 (+0.31%)

, FSTR

L.B. Foster

$13.18 /

+ (+0.00%)

, EIX

Edison International

$69.57 /

-0.12 (-0.17%)

, DNB

Dun & Bradstreet

$16.66 /

+0.21 (+1.28%)

, GDRX

GoodRx

$7.65 /

+0.085 (+1.12%)

, KR

Kroger

$52.87 /

+0.335 (+0.64%)

, BLCO

Bausch + Lomb

$16.74 /

+0.13 (+0.78%)

, SEMR

Semrush

$11.09 /

+0.05 (+0.45%)

, HNVR

Hanover Bancorp

$20.83 /

+0.11 (+0.53%)

, SLGBF

Good Natured Products

/

+

Institutional investors…

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$75.05 /

+0.47 (+0.63%)

SWTX SpringsWorks Therapeutics
$21.51 /

-0.11 (-0.51%)

SPOT Spotify
$113.53 /

+1.24 (+1.10%)

SEMR Semrush
$11.09 /

+0.05 (+0.45%)

RVMD Revolution Medicines
$19.17 /

+0.06 (+0.31%)

PMVP PMV Pharmaceuticals
$13.96 /

+0.12 (+0.87%)

LULU Lululemon
$302.50 /

+1.6 (+0.53%)

KR Kroger
$52.87 /

+0.335 (+0.64%)

GDRX GoodRx
$7.65 /

+0.085 (+1.12%)

FSTR L.B. Foster
$13.18 /

+ (+0.00%)

EIX Edison International
$69.57 /

-0.12 (-0.17%)

DNB Dun & Bradstreet
$16.66 /

+0.21 (+1.28%)

DASH DoorDash
$69.18 /

+1.12 (+1.65%)

CRWD Crowdstrike
$164.16 /

+2.095 (+1.29%)

BMY Bristol-Myers
$75.48 /

+0.325 (+0.43%)

BLCO Bausch + Lomb
$16.74 /

+0.13 (+0.78%)

AXP American Express
$169.54 /

+2.68 (+1.61%)

ACB Aurora Cannabis
$1.61 /

+0.01 (+0.63%)

SPOT Spotify
$113.53 /

+1.24 (+1.10%)

06/06/22 Raymond James
Raymond James upgrades Spotify to buy with bad news priced in
06/06/22 Raymond James
Spotify upgraded to Outperform from Market Perform at Raymond James
04/29/22 Citi
Spotify price target lowered to $165 from $240 at Citi
04/28/22 Truist
Spotify price target lowered to $150 from $210 at Truist
CRWD Crowdstrike
$164.16 /

+2.095 (+1.29%)

06/06/22 Morgan Stanley
Crowdstrike upgraded to Overweight from Equal Weight at Morgan Stanley
06/03/22 Morgan Stanley
Crowdstrike price target raised to $195 from $181 at Morgan Stanley
06/03/22 Jefferies
Crowdstrike price target raised to $215 from $200 at Jefferies
06/03/22 DA Davidson
Crowdstrike price target lowered to $235 from $280 at DA Davidson
LULU Lululemon
$302.50 /

+1.6 (+0.53%)

06/06/22 Barclays
Lululemon price target lowered to $435 from $450 at Barclays
06/06/22 Bernstein
Lululemon upgraded to Market Perform from Underperform at Bernstein
06/03/22 UBS
Lululemon price target lowered to $365 from $430 at UBS
06/03/22 Morgan Stanley
Lululemon Q1 results 'speak for themselves,' says Morgan Stanley
DASH DoorDash
$69.18 /

+1.12 (+1.65%)

06/06/22 Raymond James
DoorDash initiated with a Market Perform at Raymond James
06/03/22 DA Davidson
DoorDash price target lowered to $82 from $135 at DA Davidson
06/02/22 JMP Securities
DoorDash price target lowered to $150 from $200 at JMP Securities
06/02/22 Truist
DoorDash price target lowered to $185 from $200 at Truist
ACB Aurora Cannabis
$1.61 /

+0.01 (+0.63%)

06/06/22 Stifel
Aurora Cannabis upgraded to Hold from Sell at Stifel
05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
AXP American Express
$169.54 /

+2.68 (+1.61%)

06/06/22 Edward Jones
American Express upgraded to Buy from Hold at Edward Jones
05/12/22 Wolfe Research
Wolfe downgrades credit card issuers on 80% probability of recession
05/12/22 Wolfe Research
American Express downgraded to Peer Perform from Outperform at Wolfe Research
04/26/22 Citi
American Express price target raised to $190 from $187 at Citi
TPTX Turning Point Therapeutics
$75.05 /

+0.47 (+0.63%)

06/06/22 Cowen
Turning Point Therapeutics downgraded to Market Perform from Outperform at Cowen
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/05/22 BofA
BofA keeps Buy on Bristol-Myers, raises price target to $80
06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
BMY Bristol-Myers
$75.48 /

+0.325 (+0.43%)

06/03/22 Stifel
Bristol-Myers' offer for Turning Point Therapeutics 'fair,' says Stifel
PMVP PMV Pharmaceuticals
$13.96 /

+0.12 (+0.87%)

03/02/22 Oppenheimer
Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
03/02/22 Oppenheimer
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
09/22/21 Goldman Sachs
PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
SWTX SpringsWorks Therapeutics
$21.51 /

-0.11 (-0.51%)

06/06/22 H.C. Wainwright
SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright
05/27/22 Wedbush
SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush
05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
RVMD Revolution Medicines
$19.17 /

+0.06 (+0.31%)

05/20/22 BofA
BofA starts Revolution Medicines at Neutral with $24 price target
05/20/22 BofA
Revolution Medicines initiated with a Neutral at BofA
03/01/22 Stifel
Stifel upgrades Revolution Medicines, sees good entry point after pullback
FSTR L.B. Foster
$13.18 /

+ (+0.00%)

06/06/22 B. Riley
L.B. Foster downgraded to Neutral on inflation headwinds at B. Riley
06/06/22 B. Riley
L.B. Foster downgraded to Neutral from Buy at B. Riley
03/10/22 B. Riley
L.B. Foster price target lowered to $18 from $21 at B. Riley
08/04/21 B. Riley
L.B. Foster price target raised to $21 from $19 at B. Riley
EIX Edison International
$69.57 /

-0.12 (-0.17%)

06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
05/10/22 Mizuho
Edison International downgraded to Neutral from Buy at Mizuho
05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
DNB Dun & Bradstreet
$16.66 /

+0.21 (+1.28%)

06/06/22 RBC Capital
Dun & Bradstreet downgraded to Sector Perform from Outperform at RBC Capital
06/06/22 RBC Capital
Dun & Bradstreet downgraded to Sector Perform from Outperform at RBC Capital
05/17/22 Barclays
Dun & Bradstreet price target lowered to $18 from $22 at Barclays
05/10/22 Needham
Dun & Bradstreet price target lowered to $21 from $28 at Needham
GDRX GoodRx
$7.65 /

+0.085 (+1.12%)

06/06/22 BofA
GoodRx reinstated with a Buy at BofA
06/01/22 Baird
Baird downgrades GoodRx to Neutral amid disruption at Kroger
06/01/22 Baird
GoodRx downgraded to Neutral from Outperform at Baird
05/16/22 Baird
Baird 'hypothesizing' GoodRx PBM/pharmacy issue at Kroger may be improving
KR Kroger
$52.87 /

+0.335 (+0.64%)

06/06/22 Guggenheim
Kroger price target raised to $57 from $49 at Guggenheim
06/02/22 Deutsche Bank
Kroger price target raised to $50 from $49 at Deutsche Bank
BLCO Bausch + Lomb
$16.74 /

+0.13 (+0.78%)

06/06/22 Citi
Bausch + Lomb initiated with a Buy at Citi
05/31/22 Jefferies
Bausch + Lomb initiated with a Buy at Jefferies
05/31/22 BofA
Bausch + Lomb initiated with a Buy at BofA
05/31/22 Deutsche Bank
Bausch + Lomb initiated with a Hold at Deutsche Bank
SEMR Semrush
$11.09 /

+0.05 (+0.45%)

06/06/22 Morgan Stanley
Semrush initiated with an Equal Weight at Morgan Stanley
05/12/22 KeyBanc
KeyBanc downgrades Semrush to Sector Weight on relocation, SMB risks/expenses
05/12/22 KeyBanc
Semrush downgraded to Sector Weight from Overweight at KeyBanc
05/12/22 Jefferies
Semrush price target lowered to $10 from $15 at Jefferies
HNVR Hanover Bancorp
$20.83 /

+0.11 (+0.53%)

06/06/22 Stephens
Hanover Bancorp initiated with an Overweight at Stephens
06/06/22 Piper Sandler
Hanover Bancorp initiated with an Overweight at Piper Sandler
SLGBF Good Natured Products
/

+

06/06/22 Raymond James
Good Natured Products downgraded to Market Perform from Outperform at Raymond James
12/14/21 National Bank
Good Natured Products initiated with an Outperform at National Bank
11/02/21 Raymond James
Good Natured Products price target lowered to C$1.50 from C$2 at Raymond James
10/29/21 Canaccord
Good Natured Products price target lowered to C$1.20 from C$1.90 at Canaccord
TPTX Turning Point Therapeutics
$75.05 /

+0.47 (+0.63%)

SWTX SpringsWorks Therapeutics
$21.51 /

-0.11 (-0.51%)

SPOT Spotify
$113.53 /

+1.24 (+1.10%)

SEMR Semrush
$11.09 /

+0.05 (+0.45%)

RVMD Revolution Medicines
$19.17 /

+0.06 (+0.31%)

PMVP PMV Pharmaceuticals
$13.96 /

+0.12 (+0.87%)

LULU Lululemon
$302.50 /

+1.6 (+0.53%)

KR Kroger
$52.87 /

+0.335 (+0.64%)

GDRX GoodRx
$7.65 /

+0.085 (+1.12%)

FSTR L.B. Foster
$13.18 /

+ (+0.00%)

EIX Edison International
$69.57 /

-0.12 (-0.17%)

DNB Dun & Bradstreet
$16.66 /

+0.21 (+1.28%)

DASH DoorDash
$69.18 /

+1.12 (+1.65%)

CRWD Crowdstrike
$164.16 /

+2.095 (+1.29%)

BMY Bristol-Myers
$75.48 /

+0.325 (+0.43%)

BLCO Bausch + Lomb
$16.74 /

+0.13 (+0.78%)

AXP American Express
$169.54 /

+2.68 (+1.61%)

ACB Aurora Cannabis
$1.61 /

+0.01 (+0.63%)

  • 27
    May
  • 11
    May
  • 06
    May
  • 19
    Nov
  • 19
    Aug
  • 28
    Jun
SPOT Spotify
$113.53 /

+1.24 (+1.10%)

PMVP PMV Pharmaceuticals
$13.96 /

+0.12 (+0.87%)

LULU Lululemon
$302.50 /

+1.6 (+0.53%)

KR Kroger
$52.87 /

+0.335 (+0.64%)

DASH DoorDash
$69.18 /

+1.12 (+1.65%)

CRWD Crowdstrike
$164.16 /

+2.095 (+1.29%)

BMY Bristol-Myers
$75.48 /

+0.325 (+0.43%)

BLCO Bausch + Lomb
$16.74 /

+0.13 (+0.78%)

AXP American Express
$169.54 /

+2.68 (+1.61%)

ACB Aurora Cannabis
$1.61 /

+0.01 (+0.63%)

TPTX Turning Point Therapeutics
$75.05 /

+0.47 (+0.63%)

SWTX SpringsWorks Therapeutics
$21.51 /

-0.11 (-0.51%)

SPOT Spotify
$113.53 /

+1.24 (+1.10%)

RVMD Revolution Medicines
$19.17 /

+0.06 (+0.31%)

PMVP PMV Pharmaceuticals
$13.96 /

+0.12 (+0.87%)

LULU Lululemon
$302.50 /

+1.6 (+0.53%)

KR Kroger
$52.87 /

+0.335 (+0.64%)

GDRX GoodRx
$7.65 /

+0.085 (+1.12%)

DASH DoorDash
$69.18 /

+1.12 (+1.65%)

CRWD Crowdstrike
$164.16 /

+2.095 (+1.29%)

BMY Bristol-Myers
$75.48 /

+0.325 (+0.43%)

BLCO Bausch + Lomb
$16.74 /

+0.13 (+0.78%)

AXP American Express
$169.54 /

+2.68 (+1.61%)

ACB Aurora Cannabis
$1.61 /

+0.01 (+0.63%)

SPOT Spotify
$113.53 /

+1.24 (+1.10%)

SEMR Semrush
$11.09 /

+0.05 (+0.45%)

LULU Lululemon
$302.50 /

+1.6 (+0.53%)

KR Kroger
$52.87 /

+0.335 (+0.64%)

GDRX GoodRx
$7.65 /

+0.085 (+1.12%)

DASH DoorDash
$69.18 /

+1.12 (+1.65%)

CRWD Crowdstrike
$164.16 /

+2.095 (+1.29%)

BMY Bristol-Myers
$75.48 /

+0.325 (+0.43%)

BLCO Bausch + Lomb
$16.74 /

+0.13 (+0.78%)

AXP American Express
$169.54 /

+2.68 (+1.61%)

ACB Aurora Cannabis
$1.61 /

+0.01 (+0.63%)

Downgrade
Edison International downgraded to Neutral from Buy at UBS » 05:23
06/06/22
06/06
05:23
06/06/22
05:23
EIX

Edison International

$69.69 /

-0.64 (-0.91%)

UBS analyst Gregg Orrill…

UBS analyst Gregg Orrill downgraded Edison International to Neutral from Buy with a price target of $73, down from $75. The analyst sees the investment positives and negatives as more balanced with the stock nearing the price target. Edison shares have risen 25% over the last 12 months and 4% over the last three months, Orrill points out.

ShowHide Related Items >><<
EIX Edison International
$69.69 /

-0.64 (-0.91%)

EIX Edison International
$69.69 /

-0.64 (-0.91%)

06/06/22 UBS
Edison International downgraded to Neutral from Buy at UBS
05/10/22 Mizuho
Edison International downgraded to Neutral from Buy at Mizuho
05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
04/14/22 RBC Capital
Edison International price target raised to $82 from $73 at RBC Capital
EIX Edison International
$69.69 /

-0.64 (-0.91%)

Downgrade
Edison International downgraded to Neutral from Buy at UBS » 05:21
06/06/22
06/06
05:21
06/06/22
05:21
EIX

Edison International

$69.69 /

-0.64 (-0.91%)

UBS analyst Gregg Orrill…

UBS analyst Gregg Orrill downgraded Edison International to Neutral from Buy with a price target of $73, down from $75.

ShowHide Related Items >><<
EIX Edison International
$69.69 /

-0.64 (-0.91%)

EIX Edison International
$69.69 /

-0.64 (-0.91%)

05/10/22 Mizuho
Edison International downgraded to Neutral from Buy at Mizuho
05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
04/14/22 RBC Capital
Edison International price target raised to $82 from $73 at RBC Capital
03/30/22 Wells Fargo
Edison International price target raised to $79 from $70 at Wells Fargo
EIX Edison International
$69.69 /

-0.64 (-0.91%)

Over a month ago
Downgrade
Edison International downgraded to Neutral from Buy at Mizuho » 05:25
05/10/22
05/10
05:25
05/10/22
05:25
EIX

Edison International

$70.05 /

-0.245 (-0.35%)

Mizuho analyst Paul…

Mizuho analyst Paul Fremont downgraded Edison International to Neutral from Buy with a price target of $72, down from $82. The analyst has concerns about the impact of rising interest rates on the earnings of the company's utility subsidiary Southern California Edison. He estimates that SCE will have roughly $6B of interest-exposed disallowed debt, which is not recoverable in rates. Every 1% increase in interest rates would reduce Edison's earnings per share by 11c, Fremont tells investors in a research note.

ShowHide Related Items >><<
EIX Edison International
$70.05 /

-0.245 (-0.35%)

EIX Edison International
$70.05 /

-0.245 (-0.35%)

05/04/22 Citi
Edison International price target raised to $79 from $67 at Citi
04/14/22 RBC Capital
Edison International price target raised to $82 from $73 at RBC Capital
03/30/22 Wells Fargo
Edison International price target raised to $79 from $70 at Wells Fargo
01/31/22 Mizuho
Edison International price target raised to $82 from $77 at Mizuho
EIX Edison International
$70.05 /

-0.245 (-0.35%)

Recommendations
Edison International price target raised to $79 from $67 at Citi » 06:34
05/04/22
05/04
06:34
05/04/22
06:34
EIX

Edison International

$68.45 /

+0.57 (+0.84%)

Citi analyst Ryan Levine…

Citi analyst Ryan Levine raised the firm's price target on Edison International to $79 from $67 and keeps a Buy rating on the shares. There is an end in sight for the company's wildfire liability, Levine tells investors in a research note.

ShowHide Related Items >><<
EIX Edison International
$68.45 /

+0.57 (+0.84%)

EIX Edison International
$68.45 /

+0.57 (+0.84%)

04/14/22 RBC Capital
Edison International price target raised to $82 from $73 at RBC Capital
03/30/22 Wells Fargo
Edison International price target raised to $79 from $70 at Wells Fargo
01/31/22 Mizuho
Edison International price target raised to $82 from $77 at Mizuho
12/29/21 Argus
Edison International price target raised to $73 from $68 at Argus
EIX Edison International
$68.45 /

+0.57 (+0.84%)

Earnings
Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51  16:42
05/03/22
05/03
16:42
05/03/22
16:42
EIX

Edison International

$68.45 /

+0.57 (+0.84%)

 
ShowHide Related Items >><<
EIX Edison International
$68.45 /

+0.57 (+0.84%)

EIX Edison International
$68.45 /

+0.57 (+0.84%)

04/14/22 RBC Capital
Edison International price target raised to $82 from $73 at RBC Capital
03/30/22 Wells Fargo
Edison International price target raised to $79 from $70 at Wells Fargo
01/31/22 Mizuho
Edison International price target raised to $82 from $77 at Mizuho
12/29/21 Argus
Edison International price target raised to $73 from $68 at Argus
EIX Edison International
$68.45 /

+0.57 (+0.84%)

Earnings
Edison International reports Q1 EPS $1.07, consensus 79c » 16:41
05/03/22
05/03
16:41
05/03/22
16:41
EIX

Edison International

$68.45 /

+0.57 (+0.84%)

Reports Q1 revenue…

Reports Q1 revenue $3.97B, consensus $3.29B. "SCE continues to make solid progress in substantially improving its wildfire risk profile," said Pedro J. Pizarro, CEO. "The cornerstone of SCE's grid hardening measures is the wildfire covered conductor program. Over the past year the utility nearly doubled its miles of installed covered conductor. SCE will continue to drive this valuable program forward and by year-end expects 40% of its overhead distribution lines in high fire risk areas will be covered. We strongly believe Edison International is the best investment vehicle to participate in California's clean energy transition. SCE's approach to wildfire mitigation has shown positive results over the last three wildfire seasons and the utility is expeditiously hardening the grid every day, to the benefit of both customers and investors. As an electric-only, wires-focused utility, SCE's ongoing investment in the grid will enable an electric-led future."

ShowHide Related Items >><<
EIX Edison International
$68.45 /

+0.57 (+0.84%)

EIX Edison International
$68.45 /

+0.57 (+0.84%)

04/14/22 RBC Capital
Edison International price target raised to $82 from $73 at RBC Capital
03/30/22 Wells Fargo
Edison International price target raised to $79 from $70 at Wells Fargo
01/31/22 Mizuho
Edison International price target raised to $82 from $77 at Mizuho
12/29/21 Argus
Edison International price target raised to $73 from $68 at Argus
EIX Edison International
$68.45 /

+0.57 (+0.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.